Loading organizations...
Crocker Ventures is an independent, privately held investment firm focused on life science, healthcare, and high-technology. It strategically funds promising seed- and early-stage companies, emphasizing intellectual property management and innovative technological solutions. The firm supports nascent enterprises by providing crucial capital and guidance within these specialized industries.
Gary L. Crocker founded the venture in 2004, serving as president and chairman. Crocker established the firm based on an insight into the significant potential of early-stage advancements across life science, healthcare, and technology. His extensive background in these fields provides a robust foundation for the firm's investment approach.
Crocker Ventures partners with early-stage companies developing solutions in its core domains, offering investment to mature operations and bring innovations to market. The firm's vision is to cultivate a portfolio of enterprises poised to deliver significant progress and impact within health and advanced technology ecosystems.
Crocker Ventures has 3 tracked investments across 3 companies. The latest tracked deal is $6.0M Series A in Rebel Medicine in June 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 12, 2025 | Rebel Medicine | $6.0M Series A | Crocker Ventures | Cantina Angels, Central Texas Angel Network, Joan And TIM Fenton Founders Fund, Prosperity Solutions Capital |
| Aug 17, 2022 | IsoTalent | $5.0M Seed | Crocker Ventures, Harmon Brothers AD Ventures | Sweater Ventures |
| May 10, 2021 | TellBio | $5.0M Series A | Andy Theurer, Crocker Ventures, Genetron Health, The National Foundation For Cancer Research | — |